Ainos (AIMD) Change In Inventory : $0.02 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Ainos Change In Inventory?

Ainos's change in inventory for the quarter that ended in Dec. 2024 was $0.02 Mil. It means Ainos's inventory declined by $0.02 Mil from Sep. 2024 to Dec. 2024 .

Ainos's change in inventory for the fiscal year that ended in Dec. 2024 was $0.02 Mil. It means Ainos's inventory declined by $0.02 Mil from Dec. 2023 to Dec. 2024 .

Ainos's Total Inventories for the quarter that ended in Dec. 2024 was $0.14 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ainos's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ainos Change In Inventory Historical Data

The historical data trend for Ainos's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ainos Change In Inventory Chart

Ainos Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-0.60

0.22

0.02

Ainos Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															0.22	-	-	0.01	0.02

Ainos Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

Ainos (NAS:AIMD) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ainos's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.1525	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ainos's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.1525
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ainos's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.1525	/	0
	=	N/A

Ainos Change In Inventory Related Terms

Thank you for viewing the detailed overview of Ainos's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Ainos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ainos Inc (NAS:AIMD) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

8880 Rio San Diego Drive, Suite 800, San Diego, CA, USA, 92108

Website

https://www.ainos.com

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Executives

Meng Lin Sung	officer: Chief Financial Officer	8880 RIO SAN DIEGO DRIVE, STE 800, SAN DIEGO CA 92108
Ting-chuan Lee	director	8880 RIO SAN DIEGO DRIVE, SUITE 800, SAN DIEGO CA 92108
Ainos Inc	10 percent owner	8880 RIO SAN DIEGO DRIVE, SUITE 800, SAN DIEGO CA 92108
Pao-sheng Wei	director	10F NO 180 SECTION 2, JIANGUO N RD, TAIPEI F5 104071
Chun-hsien Tsai	director, officer: Chairman, CEO, CFO	8880 RIO SAN DIEGO DRIVE, SUITE 800, SAN DIEGO CA 92108
Chung-jung Tsai	director	8880 RIO SAN DIEGO DRIVE, SUITE 800, SAN DIEGO CA 92108
Yao-chung Chiang	director	5F, 7 ALY 69, LANE 161, TUNHUA S RD., SEC 1, TAIPEI F5 10675
Wen-han Chang	director	NO 463 FL 4, MING-SHUE ROAD, TAIPEI F5 104046
Lawrence K Lin	other: EVP - OPERATIONS	2871 NETTLE CREEK COURT, CHULA VISTA CA 92108
Hui-lan Wu	officer: Chief Financial Officer	8880 RIO SAN DIEGO DRIVE, SUITE 800, SAN DIEGO CA 92108
Hsiu-chen Chiu	director	9F-1, NO 22, AIGUO E RD, ZHONGZHENG DIST, TAIPEI F5 100408
Chung-yi Tsai	director	105 SEQUOIA CT, LOS GATOS CA 95032
Stephen T Chen	director	1 GROVE ST, UNIT 812007, WELLESLEY MA 02482-8201
Bernard H Cohen	officer: VP, CFO	4134 BUSINESS PARK DRIVE, AMARILLO TX 79110
Dennis Dean Moore	director	402 FISH HATCHERY ROAD, HAMILTON MT 59840